The evaluation of Plasma Cyclops with blood specimens from hemodialysis patients

The evaluation of Plasma Cyclops with blood specimens from hemodialysis patients - The evaluation of Plasma Cyclops

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000027562

Enrollment

Registered

2017-06-01

Start date

2015-03-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: -Patients receiving heparin as anticoagulant therapy -Hemoglobin (Hb) level of 9.0 g/dL or higher before dialysis sessions (including patients treated with ESA [erythropoiesis-stimulating agent]) -Patients undergoing dialysis for more than 1 month after initiation of dialysis -Patients who do not simultaneously receive treatment for acute illness -Patients without blood diseases or abnormal coagulation system

Exclusion criteria

Exclusion criteria: -Pregnant women -Patients with a large change in blood pressure during dialysis -Patients who are considered inappropriate as a subject by the attending physician -Patients who have participated in this study -Patients incapable of making a decision regarding participation in this study

Design outcomes

Primary

Measure	Time frame
Correlation with existing serum tubes for general chemical analytes.	—

Secondary

Measure	Time frame
Improvement of the specimens quality, such as fibrin deposition.	—

Countries

Japan

Contacts

Public ContactTakeshi Tomaru

Nippon Becton Dickinson Company, Ltd. Medical Affairs

takeshi.tomaru@bd.com03-6234-5490

Outcome results